04:47 PM, 29th Jul 2025
Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2025 inter alia to consider and approve 1. Unaudited financial results for the quarter ended 30.06.2025.2.Convene 38th Annual General Meeting of the Company. 3.To Fix Book Closure dates. 4. Employee Stock Option Plan -20255.Merger of Lifezen healthcare Pvt Ltd (Subsidiary) with Bal Pharma Ltd (Holding Company)